We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Safety monitoring and information (121)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
572 result(s) found, displaying 376 to 400
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alertsAs a precaution, health professionals are advised to avoid using all sizes and batches of AFT-distributed Provive and Sandoz Propofol 1% products until further investigation is complete.
-
Safety alerts
-
Safety alerts
-
-
Safety alerts
-
Market actions
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alertsThe TGA has tested three samples of a product labelled VigRX For Men capsules and found that two counterfeit samples contained sildenafil
-
Safety alertsThe TGA has tested four samples of a product labelled VigRX Plus tablets and found that two counterfeit samples contained tadalafil an undeclared substance
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts